Consultant Haematologist, SydPath, St Vincent's Hospital, Sydney, Australia
BIOGRAPHY
MAR 21, 2024 1:00 PM SGT
Utility of NGS in Lymphoid Malignancies and Ion AmpliSeq™ Liverpool Lymphoid Network Panel experience
Presented at:
OncomineWorld 2024: A Virtual NGS Education Meeting
Abstract
Next-generation sequencing (NGS) has become a key component of molecular testing in both myeloid and lymphoproliferative neoplasms. It can facilitate improvements in diagnostic classification, prognostication and identification of therapeutic targets. In this presentation, hear our expert share the utility of faster molecular results in lymphoid genomic profiling and their experience with the Ion Torrent Genexus System and the Ion AmpliSeq™ Liverpool Lymphoid Network Panel
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
MAY 29, 2024 | 9:00 AM
C.E. CREDITS
Histology laboratorians in the research world move fast, but those who perform cryosectioning know that these particular tissues require lighting speed and precision. Cryosectioning is the a...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
MAY 29, 2024 | 8:00 AM
A-TEEM spectroscopy is an emerging technique with huge potential for QC laboratories in the pharmaceutical and biopharmaceutical industries. We present a set of tools for A-TEEM spectroscopy...
JUN 19, 2024 | 8:30 AM
Join us for an illuminating webinar as we delve into the realm of open automation with Inpeco, the global leader in Total Laboratory Automation. Discover how their groundbreaking s...
Loading Comments...